Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MGTX

MeiraGTx Holdings plc

May 10 • 09:57AM ET

5.11

Dollar change +0.01
Percentage change 0.20	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWM IBB IWO VHT VTWO IWN IWC DFAS AVSC VTWG

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.28	Insider Own	22.88%	Shs Outstand	63.60M	Perf Week	2.20%
Market Cap	328.62M	Forward P/E	3.95	EPS next Y	1.29	Insider Trans	0.00%	Shs Float	49.59M	Perf Month	-10.82%
Income	-74.11M	PEG	-	EPS next Q	-0.40	Inst Own	50.69%	Short Float	2.27%	Perf Quarter	-21.63%
Sales	11.38M	P/S	28.88	EPS this Y	-4.87%	Inst Trans	-1.93%	Short Ratio	7.64	Perf Half Y	-1.16%
Book/sh	1.89	P/B	2.70	EPS next Y	182.72%	ROA	-24.81%	Short Interest	1.13M	Perf Year	-17.58%
Cash/sh	1.85	P/C	2.76	EPS next 5Y	2.40%	ROE	-69.92%	52W Range	3.49 - 8.35	Perf YTD	-27.21%
Dividend Est.	-	P/FCF	-	EPS past 5Y	19.75%	ROI	-35.99%	52W High	-38.80%	Beta	1.43
Dividend TTM	-	Quick Ratio	3.14	Sales past 5Y	17.92%	Gross Margin	-22.26%	52W Low	46.42%	ATR (14)	0.27
Dividend Ex-Date	-	Current Ratio	3.14	EPS Y/Y TTM	36.99%	Oper. Margin	-977.82%	RSI (14)	45.32	Volatility	5.98% 4.82%
Employees	425	Debt/Eq	0.73	Sales Y/Y TTM	-	Profit Margin	-651.19%	Recom	1.00	Target Price	17.50
Option/Short	Yes / Yes	LT Debt/Eq	0.69	EPS Q/Q	48.89%	Payout	-	Rel Volume	0.56	Prev Close	5.10
Sales Surprise	-92.81%	EPS Surprise	36.63%	Sales Q/Q	-79.09%	Earnings	May 09 BMO	Avg Volume	147.62K	Price	5.11
SMA20	0.63%	SMA50	-9.71%	SMA200	-8.91%	Trades		Volume	9,804	Change	0.20%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-23-20	Initiated	RBC Capital Mkts	Outperform	$27
Sep-15-20	Resumed	BofA Securities	Buy	$20
Sep-03-19	Initiated	Piper Jaffray	Overweight	$40
Feb-27-19	Reiterated	Chardan Capital Markets	Buy	$30 → $40
Jul-03-18	Initiated	BofA/Merrill	Buy
Jul-03-18	Initiated	Barclays	Overweight

May-09-24 01:53PM	MGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:00AM	MeiraGTx Reports First Quarter 2024 Financial and Operational Results (GlobeNewswire)
Apr-24-24 04:30PM	MeiraGTx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-18-24 04:30PM	MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference (GlobeNewswire)
Mar-14-24 10:31AM	MeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023 (GuruFocus.com) -7.09%
09:45AM	Loading…
09:45AM	MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
08:30AM	MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates (GlobeNewswire)
Feb-13-24 08:00AM	MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals (GlobeNewswire) -9.55%
Feb-01-24 07:30AM	Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors (PR Newswire)
Jan-10-24 09:55AM	Wall Street Analysts Think MeiraGTx Holdings PLC (MGTX) Could Surge 217.92%: Read This Before Placing a Bet (Zacks)
08:49AM	MeiraGTx (MGTX): Strong Industry, Solid Earnings Estimate Revisions (Zacks)
Jan-02-24 12:17PM	MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why (Zacks)
Dec-25-23 09:55AM	Wall Street Analysts Believe MeiraGTx Holdings PLC (MGTX) Could Rally 221.78%: Here's is How to Trade (Zacks)
Dec-21-23 07:07AM	J&J bets bigger on MeiraGTxs eye gene therapy (BioPharma Dive) +32.59%
07:00AM	MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million (GlobeNewswire)
04:30PM	Loading…
Nov-21-23 04:30PM	MeiraGTx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-14-23 07:21PM	MeiraGTx Holdings PLC Reports Q3 2023 Financial Results and Operational Progress (GuruFocus.com)
08:00AM	MeiraGTx Announces Third Quarter 2023 Financial and Operational Results (GlobeNewswire)
Oct-31-23 08:00AM	BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions (News Direct)
Oct-30-23 08:25AM	Sanofi invests in MeiraGTx and its gene-regulating technology (BioPharma Dive) +20.27%
07:30AM	MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities (GlobeNewswire)
Oct-24-23 08:30AM	MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress (GlobeNewswire)
Aug-10-23 09:15AM	MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
08:00AM	MeiraGTx Reports Second Quarter 2023 Financial and Operational Results (GlobeNewswire)
Aug-01-23 09:10AM	MeiraGTx Announces Poster Presentation at the 2023 American Society of Gene and Cell Therapy (ASGCT) Spotlight on Immuno-Oncology (GlobeNewswire)
Jul-19-23 08:30AM	MeiraGTx Announces its Wholly-Owned Gene Therapy Manufacturing Facility in Shannon, Ireland has Received Commercial MIA Authorization for QC Testing (GlobeNewswire) +8.04%
Jun-28-23 07:53PM	MeiraGTx Holdings PLC (MGTX) Soars 8.2%: Is Further Upside Left in the Stock? (Zacks) +8.20%
Jun-27-23 03:41PM	MeiraGTx's Investigational Drug Shows Improved Symptoms In Radiation-Induced Oral Dryness (Benzinga) -7.31%
07:30AM	MeiraGTx Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia (GlobeNewswire)
Jun-22-23 04:01PM	MeiraGTx to Present 12-month Data from All Cohorts of the Completed Phase 1 AQUAx Clinical Study and an Update on the Companys Recently Initiated Phase 2 Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Tuesday, June 27, 2023 (GlobeNewswire)
10:00AM	Loading…
Jun-16-23 10:00AM	MeiraGTx Holdings (NASDAQ:MGTX) shareholders have endured a 43% loss from investing in the stock three years ago (Simply Wall St.)
Jun-02-23 09:55AM	Does MeiraGTx Holdings PLC (MGTX) Have the Potential to Rally 320.9% as Wall Street Analysts Expect? (Zacks) +9.29%
May-17-23 09:55AM	Wall Street Analysts Predict a 314.29% Upside in MeiraGTx Holdings PLC (MGTX): Here's What You Should Know (Zacks) +10.00%
May-16-23 09:00AM	MeiraGTx Announces the Presentation of Nine Posters at the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting (GlobeNewswire) +13.82%
May-11-23 08:00AM	MeiraGTx Reports First Quarter 2023 Financial and Operational Results (GlobeNewswire) -5.97%
May-03-23 08:30AM	MeiraGTx Announces $60 Million Private Placement of Ordinary Shares (GlobeNewswire) +12.52%
Apr-21-23 08:30AM	MeiraGTx Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting (GlobeNewswire)
Apr-20-23 05:00PM	MeiraGTx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-12-23 11:41AM	MeiraGTx Holdings plc (NASDAQ:MGTX) has caught the attention of institutional investors who hold a sizeable 31% stake (Simply Wall St.)
Mar-16-23 06:06AM	A Look At The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX) (Simply Wall St.)
Mar-14-23 08:00AM	MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and Operational Results (GlobeNewswire)
Feb-13-23 03:00AM	JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics. (Barrons.com) +7.74%
Dec-13-22 01:56PM	MeiraGTx's Investigational Candidate Shows Improvement In Radiation Induced Dry Mouth Symptoms (Benzinga)
07:30AM	MeiraGTx Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia (GlobeNewswire)
06:26AM	MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 71% if they invested three years ago (Simply Wall St.)
Dec-08-22 04:30PM	MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on Tuesday, December 13, 2022 (GlobeNewswire)
Nov-22-22 04:30PM	MeiraGTx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-16-22 06:02AM	MeiraGTx Holdings Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-11-22 10:02AM	Time To Worry? Analysts Are Downgrading Their MeiraGTx Holdings plc (NASDAQ:MGTX) Outlook (Simply Wall St.)
Nov-10-22 09:25AM	MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
08:00AM	MeiraGTx Reports Third Quarter 2022 Financial and Operational Results and Receives $25 Million Investment from Johnson & Johnson Innovation - JJDC, Inc. (GlobeNewswire)
Nov-03-22 10:48AM	Institutional investors own a significant stake of 35% in MeiraGTx Holdings plc (NASDAQ:MGTX) (Simply Wall St.)
Oct-04-22 08:00AM	MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress (GlobeNewswire) +9.25%
Oct-01-22 10:00AM	Late-Breaking Phase 1/2 Data Demonstrates Safety Profile of Investigational Gene Therapy Botaretigene Sparoparvovec (AAV-RPGR) and Sustained Vision Improvement in Patients with X-Linked Retinitis Pigmentosa (XLRP) (GlobeNewswire)
Sep-16-22 02:00AM	MeiraGTxs Industry-Leading Gene Therapy Manufacturing Facility in Shannon, Ireland Formally Introduced by Head of Irish Government (GlobeNewswire)
Sep-08-22 04:30PM	MeiraGTx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-11-22 09:45AM	MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +6.71%
08:30AM	MeiraGTx Reports Second Quarter 2022 Financial and Operational Results (GlobeNewswire)
Aug-03-22 08:00AM	MeiraGTx Announces Financing Agreement with Perceptive Advisors for Up to $100 Million Secured by Manufacturing Facilities (GlobeNewswire) +19.72%
Jun-28-22 02:28PM	MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial (Benzinga)
07:00AM	MeiraGTx Announces Positive Top-Line Data from the MGT009 Phase 1/2 Clinical Study Demonstrating Safety and Improvement in Multiple Domains of Vision in X-Linked Retinitis Pigmentosa Patients treated with Botaretigene Sparoparvovec (AAV-RPGR) compared to Untreated Randomized Control (GlobeNewswire)
Jun-16-22 06:39AM	Further weakness as MeiraGTx Holdings (NASDAQ:MGTX) drops 13% this week, taking three-year losses to 67% (Simply Wall St.)
May-30-22 08:32PM	Down More Than 40%: Analysts Say These 2 Beaten-Down Stocks Are Oversold (TipRanks)
May-12-22 09:15AM	MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:00AM	MeiraGTx Reports First Quarter 2022 Financial and Operational Results (GlobeNewswire)
May-10-22 03:46PM	Companies Like MeiraGTx Holdings (NASDAQ:MGTX) Are In A Position To Invest In Growth (Simply Wall St.) +7.48%
May-09-22 05:35PM	Krystal Biotech, Inc. (KRYS) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -8.22%
May-05-22 06:15PM	Gritstone bio Inc. (GRTS) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -7.11%
May-04-22 04:01PM	MeiraGTx Presents Clinical Data on Botaretigene Sparoparvovec for the Treatment of X-Linked Retinitis Pigmentosa at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting (GlobeNewswire)
08:15AM	Horizon Therapeutics (HZNP) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-27-22 08:00AM	MeiraGTx Appoints Debra Yu, MD to Board of Directors (GlobeNewswire)
Apr-19-22 04:30PM	MeiraGTx to Participate in Upcoming Investor and Scientific Conferences (GlobeNewswire)
Mar-30-22 06:46AM	MeiraGTx Holdings PLC (MGTX) Stock Jumps 6.5%: Will It Continue to Soar? (Zacks)
Mar-15-22 02:30PM	Need To Know: Analysts Are Much More Bullish On MeiraGTx Holdings plc (NASDAQ:MGTX) Revenues (Simply Wall St.)
Mar-10-22 09:25AM	MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:00AM	MeiraGTx Reports Fourth Quarter and Full Year 2021 Financial and Operational Results (GlobeNewswire)
Mar-08-22 05:35PM	Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates (Zacks)
05:07AM	What Type Of Shareholders Make Up MeiraGTx Holdings plc's (NASDAQ:MGTX) Share Registry? (Simply Wall St.)
Mar-04-22 05:45PM	Bluebird Bio (BLUE) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Jan-27-22 08:30AM	MeiraGTx Receives Clinical Development Milestone Payment from Janssen (GlobeNewswire)
Jan-07-22 06:59AM	Recent 5.8% pullback isn't enough to hurt long-term MeiraGTx Holdings (NASDAQ:MGTX) shareholders, they're still up 106% over 3 years (Simply Wall St.)
Dec-16-21 03:49PM	A Biotech Unveils Its New Gene Control Technology (Barrons.com) -5.46%
Dec-14-21 04:30PM	MeiraGTx to Host a Virtual Research and Development Day on Gene Regulation (GlobeNewswire)
Dec-07-21 07:00AM	MeiraGTx Announces Positive Preliminary Data from the AQUAx Phase 1 Clinical Trial of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia (GlobeNewswire) +17.83%
Nov-29-21 04:30PM	MeiraGTx to Provide a Xerostomia Clinical Program Update and Host a Virtual Research and Development Day on Gene Regulation (GlobeNewswire)
Nov-10-21 09:25AM	MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	MeiraGTx Reports Third Quarter 2021 Financial and Operational Results (GlobeNewswire)
Nov-09-21 04:30PM	MeiraGTx to Participate in Upcoming Virtual Investor Conferences (GlobeNewswire)
Nov-08-21 09:29AM	MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Oct-28-21 03:05PM	Earnings Preview: MeiraGTx Holdings PLC (MGTX) Q3 Earnings Expected to Decline (Zacks)
Oct-19-21 08:30AM	MeiraGTx Announces the Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and Riboswitch Gene Regulation Platform at the European Society of Gene and Cell Therapy (ESGCT) 2021 Annual Congress (GlobeNewswire)
Oct-15-21 09:14PM	This Small Biotech Is Partnering With Johnson & Johnson. The Stock Could More Than Double. (Barrons.com) +5.86%
08:00PM	This Small Biotech Could Have a Big Winner (Barrons.com)
Oct-04-21 10:50AM	MeiraGTx Holdings plc (MGTX) Fell Out Of Favor With Hedge Funds (Insider Monkey)
Sep-28-21 04:30PM	MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-14-21 10:24AM	5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal (Zacks)
Sep-09-21 08:30AM	MeiraGTx Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa (GlobeNewswire)
Aug-12-21 01:46AM	Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher (Simply Wall St.)
Aug-11-21 09:25AM	MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	MeiraGTx Reports Second Quarter 2021 Financial and Operational Results (GlobeNewswire)

MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MGTX

MeiraGTx Holdings plc

Upgrade your FINVIZ experience